(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

UBI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

UBI

ST13

US500000073559990

Class

1

Filing

73559990

Registration

1392831

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

07/24/2026

Trademark type

Word

Nice classes

1

Filing date

09/25/1985

Registration date

05/13/1986

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/24/2026

Last transaction

07/24/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

09/13/1985

First use in commerce

09/13/1985

Drawing code

1

Owner type

03

Owner location

HAUPPAUGE, NY, US

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

UNITED BIOMEDICAL, INC.
UNITED BIOMEDICAL, INC.

Representatives

Robert E. Nail Troutman Pepper Locke LLP

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

CHEMICAL REAGENTS FOR IMMUNOLOGICAL ASSAYS

Publications

History of USPTO decisions and trademark events.

30 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/24/2026

RNL3

REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)

07/24/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/24/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/24/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

05/22/2026

NOSU

NOTICE OF SUIT

04/28/2026

NOSU

NOTICE OF SUIT

04/21/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/13/2025

NOSU

NOTICE OF SUIT

09/15/2023

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

05/02/2016

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

05/02/2016

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

05/02/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/02/2016

E89R

TEAS SECTION 8 & 9 RECEIVED

02/24/2016

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/13/2015

CFIT

CASE FILE IN TICRS

03/13/2009

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/11/2009

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

07/11/2006

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/11/2006

PLGL

ASSIGNED TO PARALEGAL

07/06/2006

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

03/28/2006

E89R

TEAS SECTION 8 & 9 RECEIVED

03/28/2006

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/18/2004

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

07/21/1992

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

05/11/1992

R.PR

REGISTERED-PRINCIPAL REGISTER

05/13/1986

PUBO

PUBLISHED FOR OPPOSITION

02/18/1986

NPUB

NOTICE OF PUBLICATION

01/19/1986

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/23/1985

DOCK

ASSIGNED TO EXAMINER

12/09/1985

Continuous trademark protection

Get notified about every new filing that threatens UBI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.